Teladoc Health Inc. (TDOC)

60.43
NYSE : Health Services
Prev Close 56.94
Day Low/High 57.90 / 61.21
52 Wk Low/High 42.08 / 89.05
Avg Volume 1.10M
Exchange NYSE
Shares Outstanding 72.04M
Market Cap 4.10B
EPS -1.50
P/E Ratio N/A
Div & Yield N.A. (N.A)
Teladoc Earns Esteemed HITRUST Security Certification

Teladoc Earns Esteemed HITRUST Security Certification

Validates Teladoc's commitment to protecting sensitive protected healthcare information  

Teladoc Completes Acquisition Of Best Doctors

Teladoc Completes Acquisition Of Best Doctors

Acquisition paves the way for Teladoc to deliver on new paradigm for healthcare delivery

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ABT, BH, CUBN, PYPL, REIS Downgrades: FRED, FSBC, TDOC Initiations: BBU, CLSD Read on to get TheStreet Quant Ratings' detailed report:

A Strong Rebound Including a Transports Breakout

Wednesday's session saw strength in small-caps as well as transports.

Teladoc To Acquire Best Doctors To Provide A Comprehensive Virtual Healthcare Delivery Platform

Acquisition gives Teladoc an international footprint and significantly expands breadth of healthcare solutions

Teladoc Reaches Analyst Target Price

In recent trading, shares of Teladoc Inc have crossed above the average analyst 12-month target price of $30.85, changing hands for $32.60/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

The TDOC Paradox: Analysts Bullish But Forecast -11.19% Fall

Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with Teladoc Inc . The average 12-month price target for TDOC — averaging the work of 13 analysts — reveals an average price target of $29.31/share.

Einstein Selects Teladoc As Telehealth Partner To Improve Care For Employees And Community

Teladoc Readiness Assessment¿ Tool Used to Set Course for Telehealth Rollout

Sirius XM Radio, Shopify, Teledoc, Tyson Foods: 'Mad Money' Lightning Round

Sirius XM Radio, Shopify, Teledoc, Tyson Foods: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Sirius XM Radio, Shopify, Teledoc, Sarepta Therapeutics, Pilgrim's Pride.

Brand Loyalty Elusive for Apparel Retailers: Cramer's 'Mad Money' Recap (Tuesday 6/6/17)

Brand Loyalty Elusive for Apparel Retailers: Cramer's 'Mad Money' Recap (Tuesday 6/6/17)

It's not about fashion missteps, says Jim Cramer. Who cares what the products look like if there's no one in the stores?

Teladoc Expands Virtual Care Capabilities In Texas

New telemedicine bill paves the way for pro-telemedicine legislation nationwide

Teladoc Reaches Analyst Target Price

In recent trading, shares of Teladoc Inc have crossed above the average analyst 12-month target price of $27.18, changing hands for $28.60/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CMT, HAE, MOMO, PCYO, PIH, PPC, RVLT, SEM, SYNL, TDOC Downgrades: LAYN, PCOM, RAND, RBPAA, SPLP Initiations: FNBG Read on to get TheStreet Quant Ratings' detailed report:

Teladoc Telehealth System Now Live At Jefferson Health

Teladoc, Inc. (NYSE:TDOC), the undisputed leader in telehealth, providing access to care for millions, announces its launch with Philadelphia-based Jefferson Health (Jefferson) to support the health system's extensive...

Teladoc Has a Healthy Looking Chart -- Prognosis is for Profits

Teladoc Has a Healthy Looking Chart -- Prognosis is for Profits

The virtual medical services company is the right prescription for a sick market.

Pursuant To New York Stock Exchange Rule 303A.08, Employee Inducement Awards Are Granted By Teladoc

Teladoc, Inc. (NYSE: TDOC) announced today that it has granted non-qualified stock options to new employees as material inducements to their hiring.

Teladoc And Accolade Partner To Help Clients And Their Members Get Maximum Value From Their Benefits

Teladoc, Inc. (NYSE:TDOC), the undisputed leader in telehealth, providing access to care for millions, announces today its alliance with Accolade, an on-demand healthcare concierge for employers, health plans and health...

Teladoc, The Undisputed Leader In Telehealth, Adds Peter Nieves As Chief Revenue Officer (Photo: Business Wire)

Teladoc, Inc. (NYSE:TDOC), the undisputed leader in telehealth, providing access to care for millions, announced today that Peter Nieves has joined the company in the newly created role of executive vice president and...

TheStreet Quant Rating: C (Hold)